Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,896 | 1,431 | 90.8% |
| Consulting Fee | $1,623 | 1 | 6.7% |
| Education | $589.89 | 12 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,368 | 251 | $0 (2024) |
| Janssen Biotech, Inc. | $2,782 | 196 | $0 (2024) |
| UCB, Inc. | $2,393 | 46 | $0 (2024) |
| Lilly USA, LLC | $1,602 | 96 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,452 | 85 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,345 | 82 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,157 | 72 | $0 (2024) |
| Amgen Inc. | $1,115 | 67 | $0 (2024) |
| PFIZER INC. | $1,002 | 92 | $0 (2024) |
| MAYNE PHARMA INC. | $972.46 | 64 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,000 | 226 | ABBVIE INC. ($623.66) |
| 2023 | $4,001 | 241 | ABBVIE INC. ($693.12) |
| 2022 | $3,620 | 235 | ABBVIE INC. ($812.68) |
| 2021 | $2,570 | 173 | AbbVie Inc. ($703.38) |
| 2020 | $3,775 | 141 | UCB, Inc. ($1,717) |
| 2019 | $1,783 | 119 | AbbVie, Inc. ($330.09) |
| 2018 | $2,262 | 149 | AbbVie, Inc. ($495.82) |
| 2017 | $2,096 | 160 | AbbVie, Inc. ($366.99) |
All Payment Transactions
1,444 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Immunology | ||||||
| 12/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.01 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $3.53 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Inflammation & Immunology | ||||||
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Immunology | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.97 | General |
| Category: Immunology | ||||||
| 12/14/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.10 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: Immunology | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, EBGLYSS | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/02/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: DERMATOLOGY | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.80 | General |
| Category: Immunology | ||||||
| 11/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.09 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: BioOncology | ||||||
| 11/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 4,425 | 8,440 | $1.1M | $288,525 |
| 2022 | 24 | 4,328 | 8,436 | $1.0M | $282,919 |
| 2021 | 28 | 4,127 | 7,793 | $948,294 | $277,180 |
| 2020 | 26 | 3,962 | 7,122 | $875,302 | $243,393 |
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,213 | 1,810 | $353,150 | $99,808 | 28.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 725 | 877 | $201,710 | $60,134 | 29.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 790 | 1,051 | $151,215 | $34,629 | 22.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 560 | 2,943 | $73,575 | $14,154 | 19.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 157 | $38,000 | $12,934 | 34.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 73 | 89 | $28,480 | $10,456 | 36.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 281 | 378 | $111,510 | $10,103 | 9.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 168 | 168 | $42,000 | $9,230 | 22.0% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 49 | 52 | $19,500 | $5,815 | 29.8% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 37 | 40 | $15,400 | $5,352 | 34.8% |
| 10061 | Complicated or multiple drainage of skin abscess | Office | 2023 | 32 | 33 | $13,200 | $4,947 | 37.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 34 | 35 | $12,250 | $4,065 | 33.2% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 18 | 19 | $6,650 | $2,230 | 33.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 67 | 226 | $10,170 | $2,149 | 21.1% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 23 | 24 | $5,940 | $2,118 | 35.7% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 14 | 14 | $4,550 | $1,667 | 36.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 21 | 22 | $6,600 | $1,623 | 24.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,600 | $1,387 | 24.8% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $3,520 | $1,346 | 38.2% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 14 | 16 | $3,910 | $1,189 | 30.4% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 12 | 20 | $2,800 | $897.06 | 32.0% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 13 | $3,525 | $834.68 | 23.7% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 20 | 27 | $3,375 | $724.64 | 21.5% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 39 | 52 | $5,980 | $479.33 | 8.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 79 | 347 | $1,388 | $253.56 | 18.3% |
About Dr. Rex Largen, MD
Dr. Rex Largen, MD is a Dermatology healthcare provider based in Lincoln, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1326036112.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rex Largen, MD has received a total of $24,108 in payments from pharmaceutical and medical device companies, with $4,000 received in 2024. These payments were reported across 1,444 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($21,896).
As a Medicare-enrolled provider, Largen has provided services to 16,842 Medicare beneficiaries, totaling 31,791 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Lincoln, NE
- Active Since 10/06/2005
- Last Updated 05/10/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1326036112
Products in Payments
- DUPIXENT (Biological) $1,961
- SKYRIZI (Biological) $1,854
- TALTZ (Drug) $1,602
- TREMFYA (Drug) $1,458
- Humira (Biological) $1,032
- RINVOQ (Biological) $883.41
- Enbrel (Biological) $788.81
- COSENTYX (Biological) $702.49
- DORYX (Drug) $683.35
- REMICADE (Biological) $666.30
- OPZELURA (Drug) $623.63
- ILUMYA (Biological) $592.77
- COSENTYX (Drug) $545.01
- EUCRISA (Drug) $510.79
- Sotyktu (Drug) $475.85
- Cimzia (Drug) $475.67
- VTAMA (Drug) $459.91
- Tremfya (Drug) $441.41
- CIBINQO (Drug) $398.24
- Otezla (Drug) $345.86
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Lincoln
Dr. Gina Weir, Md, MD
Dermatology — Payments: $13,871
Lauren Stephens, Pa, PA
Dermatology — Payments: $13,511
Dr. Casey Bowen, Md, MD
Dermatology — Payments: $10,030
David Bigler, M.d, M.D
Dermatology — Payments: $9,046
Nicolette Netz, Pa, PA
Dermatology — Payments: $5,207
Dr. Mark Heibel, Md, MD
Dermatology — Payments: $2,494